Diagnostic and therapeutic challenges

Retina

Volumn 31, Issue 5, 2011, Pages 994-997

  Ascaso, Francisco J ^a   Jimenez, Beatriz ^a   Fuertes, Miguel A ^a   Sadda, Srinivas ^a   Keane, Pearse A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EYE; HUMAN; LASER COAGULATION; LYMPH NODE HYPERPLASIA; MALE; OPHTHALMOSCOPY; PALLOR; PARS PLANA VITRECTOMY; RETINA DETACHMENT; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; SPLENOMEGALY; THORAX RADIOGRAPHY; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTE COUNT; LYMPH NODES; MALE; MIDDLE AGED; RETINAL NEOPLASMS; SPLENOMEGALY; TOMOGRAPHY, X-RAY COMPUTED; VIDARABINE; VISION, LOW; VISUAL ACUITY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS HEMORRHAGE;

EID: 79955566938     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181f98cbf     Document Type: Article

References (15)

1. Sharma T, Grewal J, Gupta S, Murray PI. Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role. Eye 2004;18:663-672. (Pubitemid 39117416)
2. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-815.
3. Löwenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med 1999;341:1051-1062. (Pubitemid 29451802)
4. Pui C-H, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535-1548.
5. Sawyers CL. Chronic myeloid leukemia. N Engl J Med 1999; 340:1330-1340. (Pubitemid 29196596)
6. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Vol 2. 4th ed. St Louis, MO: Mosby; 1997: 874-879.
7. Abdallah W, Fawzi AA. Anti-VEGF therapy in proliferative diabetic retinopathy. Int Ophthalmol Clin 2009;49:95-107.
8. Nicholson BP, Schachat AP. A review of clinical trials of anti- VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010;248:915-930.
9. Arevalo JF, Wu L, Sanchez JG, et al. Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Eye 2009;23:117-123.
10. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695.e1-1695.e15.
11. Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 2009;116:1943-1948.
12. Yang C-M, Yeh P-T, Yang C-H, Chen M-S. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 2008;146:211-217.
13. Moradian S, Ahmadieh H, Malihi M, et al. Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008;246: 1699-1705.
14. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278. (Pubitemid 44318179)
15. Arevalo JF, Maia M, Flynn HW, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-216. (Pubitemid 351224097)